[1] |
Helliwell SB, Wagner P, Kunz J, et al. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast[J]. Mol Biol Cell, 1994,5(1):105⁃18. doi: 10.1091/mbc.5.1.105.
|
[2] |
Wang H, Liu Y, Wang D, et al. The upstream pathway of mTOR⁃mediated autophagy in liver diseases[J]. Cells, 2019,8(12):1597. doi: 10.3390/cells8121597.
|
[3] |
Hay N, Sonenberg N. Upstream and downstream of mTOR[J]. Genes Dev, 2004,18(16):1926⁃45. doi: 10.1101/gad.1212704.
|
[4] |
Vignot S, Faivre S, Aguirre D, et al. mTOR⁃targeted therapy of cancer with rapamycin derivatives[J]. Ann Oncol, 2005,16(4):525⁃37. doi: 10.1093/annonc/mdi113.
|
[5] |
Liu X, Xu Y, Zhou Q, et al. PI3K in cancer: its structure, activation modes and role in shaping tumor microenvironment[J]. Future Oncol, 2018,14(7):665⁃674. doi: 10.2217/fon⁃2017⁃0588.
|
[6] |
Li G, Liu S, Wang H, et al. Ligustrazine ameliorates lipopolysaccharide induced neurocognitive impairment by activating autophagy via the PI3K/AKT/mTOR pathway[J]. Int J Mol Med, 2020,45(6):1711⁃1720. doi: 10.3892/ijmm.2020.4548.
|
[7] |
Herschbein L, Liesveld JL. Dueling for dual inhibition: means to enhance effectiveness of PI3K/Akt/mTOR inhibitors in AML[J]. Blood Rev, 2018,32(3):235⁃248. doi: 10.1016/j.blre.2017.11.006.
|
[8] |
Chen CY, Chen J, He L, Stiles BL. PTEN: tumor suppressor and metabolic regulator[J]. Front Endocrinol (Lausanne), 2018,9:338. doi: 10.3389/fendo.2018.00338.
|
[9] |
Conciatori F, Bazzichetto C, Falcone I, et al. Role of mTOR signaling in tumor microenvironment: an overview[J]. Int J Mol Sci, 2018,19(8):2453. doi: 10.3390/ijms19082453.
|
[10] |
Svitkin YV, Herdy B, Costa⁃Mattioli M, et al. Eukaryotic translation initiation factor 4E availability controls the switch between cap⁃dependent and internal ribosomal entry site⁃mediated translation[J]. Mol Cell Biol, 2005,25(23):10556⁃65. doi: 10.1128/MCB.25.23.10556⁃10565.2005.
|
[11] |
Heesom KJ, Denton RM. Dissociation of the eukaryotic initiation factor⁃4E/4E⁃BP1 complex involves phosphorylation of 4E⁃BP1 by an mTOR⁃associated kinase[J]. FEBS Lett, 1999,457(3):489⁃93. doi: 10.1016/s0014⁃5793(99)01094⁃7.
|
[12] |
Huang H, Long L, Zhou P, et al. mTOR signaling at the crossroads of environmental signals and T⁃cell fate decisions[J]. Immunol Rev, 2020,295(1):15⁃38. doi: 10.1111/imr.12845.
|
[13] |
Han C, Xing G, Zhang M, et al. Wogonoside inhibits cell growth and induces mitochondrial⁃mediated autophagy⁃related apoptosis in human colon cancer cells through the PI3K/AKT/mTOR/p70S6K signaling pathway[J]. Oncol Lett, 2018,15(4):4463⁃4470. doi: 10.3892/ol.2018.7852.
|
[14] |
Kellenberger AJ, Tauchi M. Mammalian target of rapamycin complex 1 (mTORC1) may modulate the timing of anagen entry in mouse hair follicles[J]. Exp Dermatol, 2013,22(1):77⁃80. doi: 10.1111/exd.12062.
|
[15] |
Deng Z, Lei X, Zhang X, et al. mTOR signaling promotes stem cell activation via counterbalancing BMP⁃mediated suppression during hair regeneration[J]. J Mol Cell Biol, 2015,7(1):62⁃72. doi: 10.1093/jmcb/mjv005.
|
[16] |
Laplante M, Sabatini DM. mTOR signaling in growth control and disease[J]. Cell, 2012,149(2):274⁃293. doi: 10.1016/j.cell.2012. 03.017.
|
[17] |
陈梦婷, 谢红付, 刘芳芬, 等. mTOR复合物组分Raptor和Rictor在小鼠毛囊周期中的表达与定位[J]. 中南大学学报(医学版), 2019,44(7):725⁃730. doi: 10.11817/j.issn.1672⁃7347. 2019.180389.
|
[18] |
张亦雅, 谢红付, 刘芳芬, 等. mTORC1信号通路在毛囊生长期启动时特异促进毛囊干细胞增殖[J]. 中华皮肤科杂志, 2019,52(11):821⁃825. doi: 10.35541/cjd.20190148.
|
[19] |
Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation[J]. J Clin Invest, 2015,125(1):25⁃32. doi: 10.1172/JCI73939.
|
[20] |
Zaza G, Granata S, Caletti C, et al. mTOR inhibition role in cellular mechanisms[J]. Transplantation. 2018,102(2S Suppl 1):S3⁃S16. doi: 10.1097/TP.0000000000001806.
|
[21] |
Parodi C, Hardman JA, Allavena G, et al. Autophagy is essential for maintaining the growth of a human (mini⁃)organ: evidence from scalp hair follicle organ culture[J/OL]. PLoS Biol, 2018,16(3):e2002864[2020⁃08⁃18]. https://pubmed.ncbi.nlm.nih.gov/29590104/. doi: 10.1371/journal.pbio.2002864.
|
[22] |
Chai M, Jiang M, Vergnes L, et al. Stimulation of hair growth by small molecules that activate autophagy[J]. Cell Rep, 2019,27(12):3413⁃3421.e3. doi: 10.1016/j.celrep.2019.05.070.
|
[23] |
Yoshihara N, Ueno T, Takagi A, et al. The significant role of autophagy in the granular layer in normal skin differentiation and hair growth[J]. Arch Dermatol Res, 2015,307(2):159⁃169. doi: 10.1007/s00403⁃014⁃1508⁃0.
|
[24] |
Kang S, Louboutin JP, Datta P, et al. Loss of HtrA2/Omi activity in non⁃neuronal tissues of adult mice causes premature aging[J]. Cell Death Differ, 2013,20(2):259⁃269. doi: 10.1038/cdd. 2012.117.
|
[25] |
Wang L, Guo LL, Wang LH, et al. Oxidative stress and substance P mediate psychological stress⁃induced autophagy and delay of hair growth in mice[J]. Arch Dermatol Res, 2015,307(2):171⁃181. doi: 10.1007/s00403⁃014⁃1521⁃3.
|
[26] |
李婧, 罗福玲, 吴盛旺, 等. 3⁃甲基腺嘌呤通过抑制自噬促进小鼠毛囊再生的作用研究[J]. 中国药科大学学报, 2019,50(4):468⁃474. doi: 10.11665/j.issn.1000⁃5048.20190412.
|
[27] |
Dicle O, Celik⁃Ozenci C, Sahin P, et al. Differential expression of mTOR signaling pathway proteins in lichen planopilaris and frontal fibrosing alopecia[J]. Acta Histochem, 2018,120(8):837⁃845. doi: 10.1016/j.acthis.2018.09.007.
|
[28] |
Sardiña LA, Rubin B, Jour G, et al. Differential expression of phospho⁃S6 in hair follicle tumors: evidence of mammalian target of rapamycin pathway activation[J]. J Cutan Pathol, 2019,46(4):256⁃260. doi: 10.1111/cup.13411.
|
[29] |
Hua H, Kong Q, Zhang H, et al. Targeting mTOR for cancer therapy[J]. J Hematol Oncol, 2019,12(1):71. doi: 10.1186/s13045⁃019⁃0754⁃1.
|